672 related articles for article (PubMed ID: 23078590)
1. Improvement of drug loading onto ion exchange resin by cyclodextrin inclusion complex.
Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Sila-on W; Opanasopit P
Drug Dev Ind Pharm; 2013 Nov; 39(11):1672-80. PubMed ID: 23078590
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
3. Reused cyclodextrin as a new way to deliver and enhance drug loading onto ion exchange resin.
Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Opanasopit P
Pharm Dev Technol; 2015 Nov; 20(7):827-838. PubMed ID: 24915167
[TBL] [Abstract][Full Text] [Related]
4. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
Bandarkar FS; Vavia PR
Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
[TBL] [Abstract][Full Text] [Related]
5. Density functional calculations on meloxicam-beta-cyclodextrin inclusion complexes.
Snor W; Liedl E; Weiss-Greiler P; Viernstein H; Wolschann P
Int J Pharm; 2009 Nov; 381(2):146-52. PubMed ID: 19446616
[TBL] [Abstract][Full Text] [Related]
6. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
8. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
9. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
10. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
Sridevi S; Diwan PV
Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
[TBL] [Abstract][Full Text] [Related]
11. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion.
Dalmora ME; Oliveira AG
Int J Pharm; 1999 Jul; 184(2):157-64. PubMed ID: 10387944
[TBL] [Abstract][Full Text] [Related]
13. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
14. Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound.
Van Hees T; Piel G; Evrard B; Otte X; Thunus L; Delattre L
Pharm Res; 1999 Dec; 16(12):1864-70. PubMed ID: 10644075
[TBL] [Abstract][Full Text] [Related]
15. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
16. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behaviour. A new specific HPLC method for piroxicam:cyclodextrin formulations.
Rozou S; Voulgari A; Antoniadou-Vyza E
Eur J Pharm Sci; 2004 Apr; 21(5):661-9. PubMed ID: 15066667
[TBL] [Abstract][Full Text] [Related]
17. Development of meloxicam formulations utilizing ternary complexation for solubility enhancement.
Awasthi SS; Kumar TG; Manisha P; Preeti Y; Kumar SS
Pak J Pharm Sci; 2011 Oct; 24(4):533-8. PubMed ID: 21959817
[TBL] [Abstract][Full Text] [Related]
18. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
Radia O; Rogalska E; Moulay-Hassane G
Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
[TBL] [Abstract][Full Text] [Related]
19. Understanding Surface Interaction and Inclusion Complexes between Piroxicam and Native or Crosslinked β-Cyclodextrins: The Role of Drug Concentration.
Raffaini G; Ganazzoli F
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575617
[TBL] [Abstract][Full Text] [Related]
20. Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives.
Xiliang G; Yu Y; Guoyan Z; Guomei Z; Jianbin C; Shaomin S
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Dec; 59(14):3379-86. PubMed ID: 14607235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
